Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Cardiac Allograft Vasculopathy
Interventions
DRUG

Perflutren Lipid Microsphere

Definity (injectible suspension ultrasound contrast agent) will be diluted with saline for both Pediatric and Adult subjects. For pediatric subjects under 60kg (kilogram), the dose will be 20 MicroL/kg (MicroLiter/kilogram) diluted to the same concentration used in the adult dosing. Hand Injections will be performed at baseline, Pre-peak, and peak perfusion stages.

PROCEDURE

RTMPE

Utilizes intravenous administration of biologically-inert microbubbles to assess myocardial perfusion and has demonstrated utility for identifying small vessel coronary artery disease.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Calgary

OTHER

lead

Mayo Clinic

OTHER